Risankizumab Not Beneficial for Severe Asthma in Adults

In phase 2a trial, time to first asthma worsening shorter with risankizumab compared with placebo
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Allergy, Pharmacy, Pulmonology, Journal, Source Type: news